DAY 1 AGENDA: MONDAY, NOVEMBER 14 9:00am – 4:30pm 9:00am – Welcome and Introductory Remarks 9:15 – Lessons from Seasoned Biotech Entrepreneurs Starting up a biotech company is a risky venture, but you can learn from the experiences of others who have started and grown previous successful startups. Learn the best practices and common pitfalls to avoid from startup executives with expertise in pharma, investing, and entrepreneurship. Moderator: J. Lowry Curley, AxoSim Technologies • Luis M. Branco, PhD – Co-Founder, Zalgen Labs LLC • Sandra I. Coufal, MD – President, Sibling Capital LLC • Randy Hubbell – President & CEO, Carmell Therapeutics • William Wilkison, PhD – Chief Scientific Officer, Avolynt Inc. • Brett Wingeier, PhD – Co-Founder & Chief Technical Officer, Halo Neuroscience 10:40 – Seminar: The Life Cycle of a Biotech Startup Whether developing a device, therapeutic, diagnostic, or other technology, most life sciences startups face common milestones and commercialization hurdles. Get an integrative view of entrepreneurship in the space and find out what young biotech companies can expect at various stages of development. • Rob Tucci – Managing Director, Texas Halo Fund 11:30 – Forming a Strong Founding Team From leading strategy development to assuring investors of the company’s potential, the management team at an early-stage startup is critical to its success. Learn about building the right foundation, setting up the appropriate corporate structure, finding executives, and other steps that will affect future fundraising, valuations, and more. Moderator: David Bode, New Orleans BioInnovation Center • Ben Cappiello – CEO & President, Bioceptive • Sandra I. Coufal, MD – President, Sibling Capital LLC • Bob Crutchfield – General Partner, Harbert Management Corporation • William Wilkison, PhD – Chief Scientific Officer, Avolynt Inc. More information and registration available at www.neworleansbio.com/innovationla/. Final panelists subject to change.

12:30pm – Networking Lunch 1:30 – Alternative Financing in the Life Sciences Investment capital isn’t the only option for entrepreneurs seeking to fund proof of concept work, product development, and commercialization. Learn about some alternative funding options both at the local and national levels that can help you grow your business. Moderator: Amritha Appaswami, New Orleans Business Alliance • Luis M. Branco, PhD – Co-Founder, Zalgen Labs LLC • Gregory Davenport, PhD – Vice President, The Conafay Group • Kory Hallett, PhD – Program Manager, National Cancer Institute Small Business Innovation Research Development Center • Randy Hubbell – President & CEO, Carmell Therapeutics • Roy Keller – Director, Louisiana Technology Transfer Office 2:35 – Angel Investment and Seed Funding Convincing angel investors to fund biotech startups can be difficult, but there are key steps you can take to better prepare your company for investment opportunities. Hear what angel investment groups are seeking in this space, how they prefer to be approached, and ways to improve your chances of successfully landing early funding. Moderator: Kris Khalil, New Orleans BioFund • Faz Bashi, MD – Digital Health and Life Sciences Member, Life Science Angels • Mike Eckert – Chairman, NO/LA Angel Network • Meli James – Head of New Ventures, Sultan Ventures • Cian C. Robinson – Executive Director, Lafayette General Foundation • Rob Tucci – Managing Director, Texas Halo Fund 3:45 – Keynote – Determining the Right Market *Sponsored by the New Orleans Business Alliance* Creating a successful science-based business means finding product/market fit while interpreting an ocean of data, simultaneously making headway on tough technical problems, and constantly navigating uncertainty. Learn how Halo Neuroscience used data and careful planning to build the right product for the right customers and create a business case for their company. Brett Wingeier, PhD Co-Founder & Chief Technical Officer, Halo Neuroscience More information and registration available at www.neworleansbio.com/innovationla/. Final panelists subject to change.

DAY 2 AGENDA: TUESDAY, NOVEMBER 15 9:00am – 5:30pm 9:00am – Introductory Remarks 9:15 – Transforming Health Care in Louisiana and Beyond The next phase in health innovation is all about facilitating the patient care experience and improving patient outcomes. How are providers, industry groups, and payers working to invest in novel care approaches and technologies in our fast-changing health care system? Panelists will discuss how best to accelerate truly innovative health care improvements both here in Louisiana and across the country. Moderator: Aaron Miscenich, New Orleans BioInnovation Center • Thomas Carton, PhD – Director, Health Services Research, Louisiana Public Health Institute • Bill Masterton – President and CEO, University Medical Center New Orleans • Robert S. Muscalus, DO – Medical Director, Care Transformation, Blue Cross and Blue Shield of Louisiana • Cian C. Robinson – Executive Director, Lafayette General Foundation • Aimee Quirk – Chief Executive Officer, innovationOchsner • Adam Zerda, PhD – Strategic Innovation & Business Development, BD 10:30 – Protecting Intellectual Property in the Life Sciences Intellectual property is a critical source of value for early biotech startups. Learn about critical IP protection issues from the perspectives of different stakeholders who have extensive knowledge of patenting and licensing novel technologies. Moderator: Ben Cappiello, Bioceptive • Richard Babb – Managing Director, Louisiana Funds • Paula Estrada de Martin, PhD – Associate, Baker Donelson • Hope Shimabuku – Director, Texas Regional U.S. Patent and Trademark Office • Brett Wingeier, PhD – Co-Founder & Chief Technical Officer, Halo Neuroscience

More information and registration available at www.neworleansbio.com/innovationla/. Final panelists subject to change.

11:35 – Understanding Your Customer: New Technology Adoption by Medical Providers Physicians deal with numerous pressures and drivers that affect their decisions on whether to adopt new technologies. What are some of these issues, and what do startups with new technologies need to do to show value to providers and payers? Moderator: Leigh Cosolito, New Orleans BioInnovation Center • Abigail Chaffin, MD – Assistant Professor of Plastic Surgery, Tulane University • Vinod Dasa, MD – Associate Professor, LSU Health New Orleans • Robert S. Muscalus, DO – Medical Director, Care Transformation, Blue Cross and Blue Shield of Louisiana • Korak Sarkar, MD – Neurologist, Ochsner Health System 12:30pm – Networking Lunch 1:30 – Venture Capital in the Biosciences Biotechnology product development can be a long, expensive process, and most startups will have to raise significant capital to successfully commercialize their technologies. In this panel, national venture capital investors will discuss their funds, investment strategies, and timelines, as well as best practices in approaching and working with venture capitalists. Moderator: David Rieveschl, Baker Donelson • Sandra I. Coufal, MD – President, Sibling Capital LLC • Bob Crutchfield – General Partner, Harbert Management Corporation • Joseph Lovett – Managing Director, Louisiana Funds • Charlie Plauche – Principal, S3 Ventures 2:40 – Developing Partnerships with Industry Partnerships can be a crucial source of expertise, validation, and funding for emerging startups. Learn how several major pharmaceutical and medical device companies approach early-stage partnerships, their key focus areas, and the partnering models they typically use with startups and researchers. Moderator: Shafin Khan, New Orleans BioInnovation Center • Joe Berglund, PhD – Manager, Pipeline, Strategy, & Business Analytics, Medtronic • James Hoberg, PhD – Head of Licensing & External Innovation, MilliporeSigma • Pamela Hornby, PhD – Senior Director & Research Fellow, Janssen • Joseph P. Simeone, PhD –
Director, Enabling Technologies, MRL Merck • Adam Zerda, PhD – Strategic Innovation & Business Development, BD More information and registration available at www.neworleansbio.com/innovationla/. Final panelists subject to change.

3:50 – Keynote – Research Partnerships to Transform Clinical Innovation The Michael J. Fox Foundation is dedicated to finding a cure for Parkinson's disease through an aggressively funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's today. Learn how the Foundation partners with industry and academia on fostering new research tools, better understanding Parkinson’s progression, and expediting research on novel treatments, with the aim to not only fund research but also to help improve the translational research environment itself. Rachel Rimsky Associate Director, Research Partnerships, The Michael J. Fox Foundation for Parkinson’s Research 4:30 – Closing Networking Happy Hour Mixer Presented in partnership with the New Orleans BioFund Join us for refreshments and networking with speakers and other attendees from around the region who are working to bring scientific advances to the market.

WEDNESDAY, NOVEMBER 16 9:00 am – 1:00 pm Join us at the Joy Theater (1200 Canal Street) for two additional free events on highlighting innovative new research and technologies from around the state:

The Louisiana University Technology Showcase + the 2016 BioChallenge Pitch Competition Please RSVP at www.neworleansbio.com/events.

More information and registration available at www.neworleansbio.com/innovationla/. Final panelists subject to change.